RxDoctor Payments Data

Jamie Que, MD

Family Medicine · Dublin, OHNPI 1841652187

Payments from drug & device makers

$1,878in general payments, 2019–2025

Across 111 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$939
  • AstraZeneca$178
  • Lilly USA, LLC$141
  • Novo Nordisk$136
  • Kowa Pharmaceuticals America, Inc.$109
  • Johnson & Johnson$59
  • plus $316 from 10 others

What the payments were for

  • Food & beverage$1,878100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,878 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$29,385
Medicare patients
118
Services billed
1,340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide16$35,083
EliquisApixaban26$33,975
Atorvastatin Calcium144$914
SynthroidLevothyroxine Sodium17$842
Omeprazole63$767
Gabapentin30$623
Bupropion XlBupropion Hcl18$616
Levothyroxine Sodium58$544
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$461
Tamsulosin Hcl34$453
Pantoprazole Sodium26$421
Metoprolol Succinate50$419
Duloxetine Hcl16$407
Albuterol Sulfate HfaAlbuterol Sulfate32$393
Rosuvastatin Calcium49$360

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$136$35,08316 claims
PfizerEliquis$37$33,97526 claims
AbbVieSynthroid$939$84217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →